(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
Emkay Global has a ‘buy’ rating on Metropolis Healthcare and a target price of Rs 2,200, a potential upside of 12.2%.
Related Posts
The Golden Thumb Rule: Ajit Menon on retirement planning | Tuesday July 29
The Golden Thumb Rule: Ajit Menon on retirement planning | Tuesday July 29
India rate cut | RBI | Fitch: RBI may push back rate cuts a bit; a 25 bps cut possible in next few months: Jeremy Zook, Fitch
Jeremy Zook, Director, APAC Sovereign Ratings, Fitch Ratings, says he expects a 25 bps rate cut in the next few months. Inflation has been relatively contained but food inflation, has been a bit on the higher side and persistently so. Core inflation is hovering just above 3%. Zook says the balance of risks is towards […]
Garuda Construction GMP: Should investors prepare for losses on debut tomorrow?
Garuda Construction and Engineering is set to make its stock market debut on Tuesday. While the IPO received a decent subscription response of 7.5 times, the grey market premium (GMP) currently stands at 0, indicating a potential for a flat or even negative listing. The company’s financial performance was robust in FY23, but the election […]
